U.S. Companion Animal Health Market Size, Share & Trends Report

U.S. Companion Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Equine, Cats), By Product (Vaccines, Pharmaceuticals, Diagnostics), By Distribution Channel, By End Use, And Segment Forecasts, 2019 - 2026

  • Published Date: Oct, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-3-68038-960-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 152

Table of Contents

Chapter 1 Research Methodology & Scope
                  1.1 Market Segmentation & Scope
                      1.1.1 Type
                      1.1.2 Product
                      1.1.3 Distribution Channel
                      1.1.4 End Use
                      1.1.5 Etimates & Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database:
                      1.3.2 Gvr’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research:
                      1.3.5 Details Of Primary Research
                  1.4 Information or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                  1.7 List of Secondary Sources
                  1.8 List of Primary Sources
                  1.9 Abbreviations
                  1.10 Objectives
                      1.10.1 Objective 1:
                      1.10.2 Objective 2:
Chapter 2 Executive Summary
                  2.1 Market Outlook
                      2.1.1 U.S. Companion Animal Health Market Outlook, 2014 - 2026 (USD Million)
                  2.2 Segment Outlook
                  2.3 Competitive Outlook
Chapter 3 U.S. Companion Animal Health Market Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Analysis
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Product Pipeline Analysis
                  3.4 Industry Value Chain Analysis
                      3.4.1 Cost Structure Analysis
                      3.4.2 Distribution Channel Analysis
                      3.4.3 User Perspective Analysis
                  3.5 Technology Overview
                      3.5.1 Technology Timeline Veterinary Orthopedics Changing Technology & Adoption
                  3.6 Regulatory Framework
                      3.6.1 Reimbursement Framework
                      3.6.2 Standards & Compliances In The U.S.
                  3.7 U.S. Companion Animal Health Market dynamics
                      3.7.1 Market Driver Analysis
                      3.7.2 Market Restraint Analysis
                      3.7.3 Industry Challenges
                  3.8 U.S. Companion Animal Health Market Analysis Tools
                      3.8.1 Industry Analysis: Poter’s
                      3.8.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                      3.8.3 Major Deals & Strategic Alliances Analysis
                      3.8.4 Market Entry Strategies
Chapter 4 U.S. Companion Animal Health Market: Competitive Analysis
                  4.1 Recent Developments & Impact Analysis, By Key Market Participants
                      4.1.1 Market Participation Categorization
                  4.2 Vendor Landscape
                      4.2.1 List Of Key Distributors And Channel Partners
                      4.2.2 Key Customers
                  4.3 Opportunity Analysis
                      4.3.1 U.S. Companion Animal Health: Company Market Share Analysis
                      4.3.2 Public Companies
                      4.3.3 Private Companies
Chapter 5 U.S. Companion Animal Health Market: Animal Type Estimates & Trend Analysis
                  5.1 Animal Type Market Share Analysis, 2018 & 2026
                  5.2 Animal Type Dashboard
                  5.3 U.S. Companion Animal Health Market, by Animal Type, 2014 to 2026
                  5.4 Dogs
                      5.4.1 Dogs Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  5.5 Equine
                      5.5.1 Equine Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  5.6 Cats
                      5.6.1 Cats Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  5.7 Others
                      5.7.1 Other Companion Animals Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 6 U.S. Companion Animal Health Market: Product Estimates & Trend Analysis
                  6.1 Product Market Share Analysis, 2018 & 2026
                  6.2 Product Dashboard
                  6.3 U.S. Companion Animal Health Market, by Product, 2014 to 2026
                  6.4 Vaccines
                      6.4.1 Vaccines Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  6.5 Pharmaceuticals
                      6.5.1 Pharmaceuticals Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                      6.5.2 OTC
                      6.5.3 Prescription
                  6.6 Feed Additives
                      6.6.1 Feed Additives Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  6.7 Diagnostics
                      6.7.1 Diagnostics Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  6.8 Others
Chapter 7 U.S. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
                  7.1 Distribution Channel Market Share Analysis, 2018 & 2026
                  7.2 Distribution Channel Dashboard
                  7.3 U.S. Companion Animal Health Market By Distribution Channel 2014 To 2026
                      7.3.1 Retail
                      7.3.2 Retail Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  7.4 E-Commerce
                      7.4.1 E-Commerce Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  7.5 Hospital Pharmacies
                      7.5.1 Hospital Pharmacy Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 8 U.S. Companion Animal Health Market: End-use Estimates & Trend Analysis
                  8.1 End-use Market Share Analysis, 2018 & 2026
                  8.2 End-use Dashboard
                  8.3 U.S. Companion Animal Health Market by End-use, 2014 to 2026
                  8.4 Point-of-care/In-house Testing
                      8.4.1 Point-Of-Care/In-House Testing Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  8.5 Veterinary Hospitals & Clinics
                      8.5.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2014 - 2026 (USD Million)
                  8.6 Others
                      8.6.1 Others Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 9 Company Profiles
                  9.1 Merck Animal Health
                      9.1.1 Company Overview
                      9.1.2 Financial Performance
                      9.1.3 Product Benchmarking
                      9.1.4 Strategic Initiatives
                  9.2 Ceva Santé Animale
                      9.2.1 Company Overview
                      9.2.2 Financial Performance
                      9.2.3 Product Benchmarking
                      9.2.4 Strategic Initiatives
                  9.3 Vetiquinol S.A.
                      9.3.1 Company Overview
                      9.3.2 Financial Performance
                      9.3.3 Product Benchmarking
                      9.3.4 Strategic Initiatives
                  9.4 Zoetis
                      9.4.1 Company Overview
                      9.4.2 Financial Performance
                      9.4.3 Product Benchmarking
                      9.4.4 Strategic Initiatives
                  9.5 Boehringer Ingelheim GmbH
                      9.5.1 Company Overview
                      9.5.2 Financial Performance
                      9.5.3 Product Benchmarking
                      9.5.4 Strategic Initiatives
                  9.6 Bayer AG
                      9.6.1 Company Overview
                      9.6.2 Financial Performance
                      9.6.3 Product Benchmarking
                      9.6.4 Strategic Initiatives
                  9.7 Elanco
                      9.7.1 Company Overview
                      9.7.2 Financial Performance
                      9.7.3 Product Benchmarking
                      9.7.4 Strategic Initiatives
                  9.8 Virbac, Inc.
                      9.8.1 Company Overview
                      9.8.2 Financial Performance
                      9.8.3 Product Benchmarking
                      9.8.4 Strategic Initiatives
                  9.9 Norbrook Inc.
                      9.9.1 Company Overview
                      9.9.2 Financial Performance
                      9.9.3 Product Benchmarking
                      9.9.4 Strategic Initiatives
                  9.10 Dechra Pharmaceuticals
                      9.10.1 Company Overview
                      9.10.2 Financial Performance
                      9.10.3 Product Benchmarking
                      9.10.4 Strategic Initiatives
                  9.11 Patterson Companies, Inc.
                      9.11.1 Company Overview
                      9.11.2 Financial Performance
                      9.11.3 Product Benchmarking
                      9.11.4 Strategic Initiatives
                  9.12 Vedco Inc.
                      9.12.1 Company Overview
                      9.12.2 Financial Performance
                      9.12.3 Product Benchmarking
                      9.12.4 Strategic Initiatives
                  9.13 MWI Animal Health
                      9.13.1 Company Overview
                      9.13.2 Financial Performance
                      9.13.3 Product Benchmarking
                      9.13.4 Strategic Initiatives
                  9.14 Covetrus
                      9.14.1 Company Overview
                      9.14.2 Financial Performance
                      9.14.3 Product Benchmarking
                      9.14.4 Strategic Initiatives
                  9.15 Ellevet Sciences
                      9.15.1 Company Overview
                      9.15.2 Financial Performance
                      9.15.3 Product Benchmarking
                      9.15.4 Strategic Initiatives
                  9.16 Nutramax Laboratories Veterinary Sciences, Inc.
                      9.16.1 Company Overview
                      9.16.2 Product Benchmarking
                      9.16.3 Strategic Initiatives


List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 US companion animal drug approvals from 2016 to 2018
Table 4 Products in pipeline
Table 5 Deals & strategic alliances in U.S. Companion Animal Health
Table 6 List of Distributors
Table 7 List of key emerging companies
Table 8 U.S. companion animal health market, by type, 2014 - 2026 (USD Million)
Table 9 U.S. Companion animal health market, by product, 2014 - 2026 (USD Million)
Table 10 U.S. pharmaceuticals market, by type, 2014 - 2026 (USD Million)
Table 11 U.S. companion animal health market, by distribution channel, 2014 - 2026 (USD Million)
Table 12 U.S. companion animal health market, by end use, 2014 - 2026 (USD Million)


List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 U.S. companion animal health market revenue, 2014 - 2026 (USD Million)
Fig. 11 U.S. Companion animal health market snapshot
Fig. 12 Companion animal health market revenue, 2014 - 2026 (USD Million)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Drug development process for companion animal segment
Fig. 15 Companion animal health: Market influencing factors
Fig. 16 Companion animal health: Market dynamics
Fig. 17 U.S. companion animal health market dynamics
Fig. 18 U.S. Companion Animal Health market driver impact
Fig. 19 U.S. Pet ownership statistics by animal type
Fig. 20 U.S. Pet ownership statistics till 2018
Fig. 21 U.S. Companion Animal Health market restraint impact
Fig. 22 U.S. Companion Animal Health market: Porter’s five forces analysis
Fig. 23 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 24 Market entry strategies
Fig. 25 Market participant categorization
Fig. 26 Company Market Share Analysis, 2018 (%)
Fig. 27 Competitive dashboard analysis
Fig. 28 Company market position analysis
Fig. 29 U.S. companion animal health market: Animal type movement analysis
Fig. 30 U.S. companion animal health market animal type dashboard
Fig. 31 U.S. companion animal health market by animal type
Fig. 32 U.S. Dogs market, 2014 - 2026 (USD Million)
Fig. 33 U.S. Equine market, 2014 - 2026 (USD Million)
Fig. 34 U.S. Cats market, 2014 - 2026 (USD Million)
Fig. 35 U.S. other companion animals market, 2014 - 2026 (USD Million)
Fig. 36 U.S. companion animal health market: Product movement analysis
Fig. 37 U.S. companion animal health product dashboard
Fig. 38 U.S. companion animal health Market, by Product, 2014 to 2026
Fig. 39 U.S. vaccines market, 2014 - 2026 (USD Million)
Fig. 40 U.S. pharmaceuticals market, 2014 - 2026 (USD Million)
Fig. 41 U.S. OTC drugs market, 2014 - 2026 (USD Million)
Fig. 42 U.S. prescription drugs market, 2014 - 2026 (USD Million)
Fig. 43 U.S. feed additives market, 2014 - 2026 (USD Million)
Fig. 44 U.S. diagnostics market, 2014 - 2026 (USD Million)
Fig. 45 U.S. others market, 2014 - 2026 (USD Million)
Fig. 46 U.S. companion animal health market: Distribution channel movement analysis
Fig. 47 U.S. companion animal health market distribution channel dashboard
Fig. 48 U.S. Companion Animal Health Market by Distribution Channel 2014 to 2026
Fig. 49 U.S. retail market, 2014 - 2026 (USD Million)
Fig. 50 U.S. e-commerce market, 2014 - 2026 (USD Million)
Fig. 51 U.S. hospital pharmacy market, 2014 - 2026 (USD Million)
Fig. 52 U.S. companion animal health market: End-use movement analysis
Fig. 53 U.S. companion animal health market end-use dashboard
Fig. 54 U.S. companion animal health Market by End-use, 2014 to 2026
Fig. 55 U.S. point-of-care/in-house testing market, 2014 - 2026 (USD Million)
Fig. 56 U.S. veterinary hospitals & clinics market, 2014 - 2026 (USD Million)
Fig. 57 U.S. others market, 2014 - 2026 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.